Alcoholism & Drug Abuse Weekly最新文献

The 36th annual national leadership forum of CADCA will be held February 2-5, 2026 in National Harbor, Maryland. For more information, go to https://www.cadca.org/signature-events/

The 2026 annual conference of NAADAC, The Association for Addiction Professionals (NAADAC) is gearing up for its August 29-31 meeting in Kansas City, Missouri. Last week, NAADAC requested proposals to present at EMPOWER 2026: the Annual Conference.

The American Pharmacists Association (APhA) called it a “major legislative victory” — on December 2, new language in the SUPPORT Act (see page 1) empowers pharmacists by permitting APhA and the Accreditation Council for Pharmacy Education (ACPE) to offer eight hours of continuing pharmacy education (CPE) training for pharmacists. This training will fulfill requirements under law for prescribing controlled substances – including buprenorphine. “Pharmacists are on the front lines of patient care, and this provision recognizes their critical role in addressing the opioid epidemic,” said Michael D. Hogue, executive vice president and CEO of APhA. “By enabling pharmacists to prescribe buprenorphine with appropriate training, we are expanding access to treatment and saving lives.”

Although there is nothing in the writings or traditions of Alcoholics Anonymous (AA) that discourages members' use of medication treatments, including agonists for opioid use disorder (OUD), authors of a newly published perspective article say many members of 12-step recovery groups hear quite a different message within the fellowship.

Charging disability discrimination, the federal Equal Employment Opportunity Commission (EEOC) has sued two concrete companies for refusing employment applications from people in treatment for opioid use disorder (OUD) with methadone.

The governmental shutdown ended Nov. 12, allowing Congress to finally plan spending for fiscal year 2026. On Nov. 24, the Senate Appropriations Committee released its Financial Services and General Government (FSGG) appropriations bill, which includes funding for the Drug-Free Communities (DFC) Program, Comprehensive Addiction and Recovery Act (CARA) Section 103 enhancement grants, and the High Intensity Drug Trafficking Area (HIDTA) Program. The House already released its version of the bill.

After the release of the third season of The White Lotus on HBO Max in February, 2025, internet searches for lorazepam, a benzodiazepine, shot up, according to a study published online November 14, 2025 in JAMA Health Forum. The central storyline involved a character who frequently used lorazepam for anxiety, and there were frequent on-screen references to this medication.

A review published in JAMA Network in November found “insufficient” evidence supporting the use of cannabis for most medical purposes. This isn't going to stop all people from using it, however, because many don't use it for medical reasons.

This is tax season. It's also fundraising season. For the substance use field, that can mean crowdfunding. We got some good advice from Mark Gallegos, partner with Porte Brown accountants of Elgin, Illinois. “GoFundMe and similar crowdfunding campaigns fall into a quirky corner of the tax code because the IRS doesn't have a single, unified set of rules for them,” he said. “The taxability really depends on the intent behind the payment.”

Researchers have found that REBOOT, a repeated dose motivational interviewing intervention, had a statistically significant effect on opioid overdose in two cities — San Francisco and Boston — where fentanyl was the main street opioid. According to the report, published in Addiction on Nov. 19, this intervention doesn't work in the era of fentanyl. Compared with a control group, there were no differences in opioid use or overdoses.